SCHEMBL4924259

SCHEMBL4924259

CCOC(=O)c1ccc(Cc2cc(Cl)ccc2OC2CCCC2)o1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 2/20 0.47
ALDH1A1 P00352 5/20 0.47
GAA P10253 2/20 0.47
TP53 P04637 2/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
MAOB P27338 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 2/20 0.41
MAPT P10636 3/20 0.40
LMNA P02545 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAOA P21397 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
PDE5A O76074 1/20 0.40
PDE1A P54750 1/20 0.40
PDE1B Q01064 1/20 0.40
PDE4D Q08499 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4922863 0.97 PTGER1 (0.49) PTGER1ALDH1A1GAATP53CYP2D6
SCHEMBL14008067 0.86 PTGER1 (0.52) PTGER1ALDH1A1KMT2APOLBNPC1
SCHEMBL4914494 0.85 PTGER1 (0.52) PTGER1ALDH1A1GAATP53CYP2D6
SCHEMBL4919440 0.84 PTGER1 (0.64) PTGER1KMT2APOLBNPC1RAB9A
SCHEMBL3223740 0.84 ALDH1A1 (0.53) PTGER1ALDH1A1GAATP53MAOB
SCHEMBL4923927 0.81 PTGER1 (0.55) PTGER1ALDH1A1GAATP53MAOB
SCHEMBL4923327 0.81 PTGER1 (0.55) PTGER1ALDH1A1GAATP53CYP2D6
SCHEMBL4927573 0.80 PTGER1 (0.52) PTGER1ALDH1A1GAATP53MAOB
SCHEMBL4924174 0.79 PTGER1 (0.53) PTGER1ALDH1A1GAATP53MAOB
SCHEMBL4765586 0.79 PTGER1 (0.74) PTGER1ALDH1A1GAACYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287430-A1 Furan Compounds Useful As Ep1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
US-20080287430-A1 Furan Compounds Useful As Ep1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
US-20080287430-A1 Furan Compounds Useful As Ep1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287430-A1 Furan Compounds Useful As Ep1 Receptor Antagonists PTGER1, PTGER2, PTGER3 PTGER1 1/4885ALDH1A1 1015/4885GAA 4729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.